Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart disease.

about

Right heart dysfunction and failure in heart failure with preserved ejection fraction: mechanisms and management. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.

P2860

Q47890686-1FA6D989-BE2A-44EA-B213-4BD88F11F4E3

P2860

Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart disease.

Item

http://www.wikidata.org/entity/Q42782025

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Pulmonary artery denervation f ...... condary to left heart disease.

@en

Pulmonary artery denervation f ...... condary to left heart disease.

@nl

type

Item

label

Pulmonary artery denervation f ...... condary to left heart disease.

@en

Pulmonary artery denervation f ...... condary to left heart disease.

@nl

prefLabel

Pulmonary artery denervation f ...... condary to left heart disease.

@en

Pulmonary artery denervation f ...... condary to left heart disease.

@nl

P1476

Pulmonary artery denervation f ...... condary to left heart disease.

@en

P2093

Du-Jiang Xie

http://www.w3.org/2001/XMLSchema#string

Feng-Fu Zhang

http://www.w3.org/2001/XMLSchema#string

Hang Zhang

http://www.w3.org/2001/XMLSchema#string

Juan Zhang

http://www.w3.org/2001/XMLSchema#string

Shao-Liang Chen

http://www.w3.org/2001/XMLSchema#string

Xiaoming Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

Pulmonary hypertension in heart failure preserved ejection fraction: prevalence, pathophysiology, and clinical perspectives

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS):

Pulmonary hypertension in advanced heart failure.

Hemodynamic, functional, and clinical responses to pulmonary artery denervation in patients with pulmonary arterial hypertension of different causes: phase II results from the Pulmonary Artery Denervation-1 study.

Pulmonary hypertension associated with left heart disease: characteristics, emerging concepts, and treatment strategies.

Pulmonary hypertension due to left heart diseases.

Experimental pulmonary hypertension produced by surgical and chemical denervation of the pulmonary vasculature.

Pulmonary artery denervation reduces pulmonary artery pressure and induces histological changes in an acute porcine model of pulmonary hypertension

Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo.

Additional use of a phosphodiesterase 5 inhibitor in patients with pulmonary hypertension secondary to chronic systolic heart failure: a meta-analysis.

P304

240-243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

case report

P356

10.1086/685550

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

289556458

http://www.w3.org/2001/XMLSchema#string

P698

27252851

http://www.w3.org/2001/XMLSchema#string

P932

4869929

http://www.w3.org/2001/XMLSchema#string

Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart disease.

about

P2860

P2860

Pulmonary artery denervation for treatment of a patient with pulmonary hypertension secondary to left heart disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932